Equity Profile

FMS

Fresenius Medical Care AG

Health CareHealth Care Services$13.1B

Aug4Tue

Pre-Earnings Brief

UpcomingQ2-2023After Close9:00 AM EDT

Company Snapshot

Fresenius Medical Care AG (FMS) is a leading provider of products and services for individuals with chronic kidney failure. Operating in the health care sector, the company plays a crucial role in providing dialysis treatment and related services, which are vital as the global population ages and the prevalence of kidney disease increases.

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.

$0.50

Revenue

Revenue figures will provide insight into the overall demand for Fresenius's services and products, reflecting the company's market position.

$4.6B

Wall Street expectations, options signals, track record, and call prep available with Pro.

FMS Q2-2023 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

25%

Avg EPS Surprise

-6.74%

Avg Stock Reaction

-1.23%

Last Quarter Recap

In Q1-2023, Fresenius reported an EPS of $0.17, slightly missing the estimate of $0.18. The stock reacted with a minor decline of 0.09% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Fresenius to report an EPS of $0.50 and revenue of $4.6 billion for Q2-2023. The market is closely watching how the company addresses ongoing challenges in the healthcare sector.

Bull Case

If Fresenius can beat EPS estimates and show strong revenue growth, it may indicate a recovery in demand for its services, leading to a positive market reaction.

Bear Case

Conversely, if the company misses its earnings targets again, it could signal deeper issues within the business, resulting in negative investor sentiment.

Key Metrics to Watch

EPS

$0.50

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.

Revenue

$4.6B

Revenue figures will provide insight into the overall demand for Fresenius's services and products, reflecting the company's market position.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the EPS meet or exceed the consensus estimate of $0.50?

This figure is critical as it will indicate the company's ability to manage costs and generate profits in a challenging environment.

What are the revenue expectations for the quarter, particularly in key markets?

Understanding revenue performance will help gauge demand for Fresenius's services and the overall health of the business.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate the potential for Fresenius to rebound, given recent investments in technology and patient care that could drive efficiency and growth.

Supporting Evidence

The options market is pricing in a 24.8% move, indicating expectations for significant volatility, which may not align with the actual performance.

Fresenius has historically shown resilience in challenging quarters, with potential for recovery not fully reflected in current estimates.

Key Risk

If the company reports an EPS above $0.50, it could challenge the bearish sentiment and shift investor perception.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Fresenius can recover from recent earnings misses and demonstrate growth in a competitive healthcare landscape.

Bull Confirmed If

An EPS of $0.53 or higher would confirm strong operational performance and investor confidence.

Bear Confirmed If

An EPS below $0.47 would raise concerns about the company's profitability and market position.

Pre-Earnings Positioning

Options Market

Implied Move

±24.8%

Historical Avg

±2.7%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±24.8% while FMS has averaged ±2.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

44.1%

Calls (500)P/C Ratio: 1.60Puts (800)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing rich setup in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 3.6%, with a raw directional average of -1.3% (modestly negative historical bias).

Edge

Institutional Ownership

Smart-money positioning from the most recent 13F filings.

Top holders trimming

Institutional

8.64%

of float

Insider

0.00%

of float

Holders

255

institutions

Top Holders· as of Dec 2025

Pzena Investment Management LLC
14,752,836 sh · $335.9M
2.64%
-0.4%

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Fresenius beats expectations, history suggests the stock could see a modest increase, confirming a recovery narrative.

In-Line / Cautious

If results are in line with expectations, the stock may experience limited movement as investors await further guidance.

Miss

A miss could lead to a decline, with historical data indicating an average drop of around 1.23% following earnings misses.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on cost management strategies and their impact on profitability.
2Insights into patient volume trends and demand for dialysis services.
3Comments on competitive pressures in the healthcare market.
4Details on any new product or service offerings that could drive future growth.
5Management's outlook on the regulatory environment and its impact on operations.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.

$0.50

Revenue

Revenue figures will provide insight into the overall demand for Fresenius's services and products, reflecting the company's market position.

$4.6B

Wall Street expectations, options signals, track record, and call prep available with Pro.

FMS Q2-2023 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

25%

Avg EPS Surprise

-6.74%

Avg Stock Reaction

-1.23%

Last Quarter Recap

In Q1-2023, Fresenius reported an EPS of $0.17, slightly missing the estimate of $0.18. The stock reacted with a minor decline of 0.09% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Fresenius to report an EPS of $0.50 and revenue of $4.6 billion for Q2-2023. The market is closely watching how the company addresses ongoing challenges in the healthcare sector.

Bull Case

If Fresenius can beat EPS estimates and show strong revenue growth, it may indicate a recovery in demand for its services, leading to a positive market reaction.

Bear Case

Conversely, if the company misses its earnings targets again, it could signal deeper issues within the business, resulting in negative investor sentiment.

Key Metrics to Watch

EPS

$0.50

Earnings per share is a key indicator of profitability and will show how well the company is managing costs and generating income.

Revenue

$4.6B

Revenue figures will provide insight into the overall demand for Fresenius's services and products, reflecting the company's market position.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the EPS meet or exceed the consensus estimate of $0.50?

This figure is critical as it will indicate the company's ability to manage costs and generate profits in a challenging environment.

What are the revenue expectations for the quarter, particularly in key markets?

Understanding revenue performance will help gauge demand for Fresenius's services and the overall health of the business.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate the potential for Fresenius to rebound, given recent investments in technology and patient care that could drive efficiency and growth.

Supporting Evidence

The options market is pricing in a 24.8% move, indicating expectations for significant volatility, which may not align with the actual performance.

Fresenius has historically shown resilience in challenging quarters, with potential for recovery not fully reflected in current estimates.

Key Risk

If the company reports an EPS above $0.50, it could challenge the bearish sentiment and shift investor perception.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Fresenius can recover from recent earnings misses and demonstrate growth in a competitive healthcare landscape.

Bull Confirmed If

An EPS of $0.53 or higher would confirm strong operational performance and investor confidence.

Bear Confirmed If

An EPS below $0.47 would raise concerns about the company's profitability and market position.

Pre-Earnings Positioning

Options Market

Implied Move

±24.8%

Historical Avg

±2.7%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±24.8% while FMS has averaged ±2.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

44.1%

Calls (500)P/C Ratio: 1.60Puts (800)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter miss + options pricing rich setup in Health Care

n=30

Fade rate: 13 of 29 (45%)

Edge

Institutional Ownership

Smart-money positioning from the most recent 13F filings.

Top holders trimming

Institutional

8.64%

of float

Insider

0.00%

of float

Holders

255

institutions

Top Holders· as of Dec 2025

Pzena Investment Management LLC
14,752,836 sh · $335.9M
2.64%
-0.4%

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Fresenius beats expectations, history suggests the stock could see a modest increase, confirming a recovery narrative.

In-Line / Cautious

If results are in line with expectations, the stock may experience limited movement as investors await further guidance.

Miss

A miss could lead to a decline, with historical data indicating an average drop of around 1.23% following earnings misses.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on cost management strategies and their impact on profitability.
2Insights into patient volume trends and demand for dialysis services.
3Comments on competitive pressures in the healthcare market.
4Details on any new product or service offerings that could drive future growth.
5Management's outlook on the regulatory environment and its impact on operations.